PRESS RELEASE published on 05/23/2023 at 14:05, 2 years 9 months ago Hardman & Co Research on Chesnara plc (CSN): Nice little acquisition
PRESS RELEASE published on 05/18/2023 at 14:30, 2 years 10 months ago Hardman & Co Q&A on Surface Transforms (SCE): Production ramp up secured in a potential £2bn a year market
PRESS RELEASE published on 05/17/2023 at 08:15, 2 years 10 months ago Hardman & Co Research on Shield Therapeutics (STX): Reassuring 1Q’23 Accrufer prescriptions
PRESS RELEASE published on 05/10/2023 at 08:15, 2 years 10 months ago Hardman & Co Research on Anglo Asian Mining (AAZ): Growth in copper production poised to explode
PRESS RELEASE published on 05/09/2023 at 08:30, 2 years 10 months ago Hardman & Co Research on Surface Transforms (SCE): A major quantum production ramp up now secured
PRESS RELEASE published on 05/04/2023 at 15:30, 2 years 10 months ago Hardman & Co Q&A on Chesnara plc (CSN): Strong cash generation through tough markets
PRESS RELEASE published on 05/03/2023 at 14:45, 2 years 10 months ago Hardman & Co Q&A on Arbuthnot Banking Group (ARBB): Core and new franchises growth in profits and loans
PRESS RELEASE published on 05/02/2023 at 17:15, 2 years 10 months ago Hardman & Co Research on The International Stock Exchange (TISE): Resilient performance in difficult year
PRESS RELEASE published on 04/28/2023 at 11:05, 2 years 10 months ago Hardman & Co Research | City of London Investment Group (CLIG): Positive markets offset by revenue margins
PRESS RELEASE published on 04/27/2023 at 13:35, 2 years 10 months ago Hardman & Co Video | Surface Transforms (SCE) Presentation and Q&A with the Board
Published on 03/23/2026 at 11:30, 27 minutes ago Trans Canada Gold Provides Update on Non-Brokered Private Placement and Flow-through Private Placement for Drilling at the Harrison Lake District Scale Gold Property Acquisition
Published on 03/23/2026 at 08:00, 3 hours 57 minutes ago ABRIDGED, PRELIMINARY AND UNAUDITED QUARTERLY AND FULL YEAR RESULTS AND DETAILS OF MANAGEMENT CONFERENCE Call for the Fourth Quarter and Full Year Ended December 31, 2025 ("The Quarter" or "Q4 2025" and "FY 2025" Respectively)
Published on 03/23/2026 at 02:00, 9 hours 57 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/23/2026 at 11:44, 13 minutes ago Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
Published on 03/23/2026 at 11:30, 27 minutes ago EQS Group lance un module de gestion des risques pour faciliter la surveillance continue des risques liées aux données et à l’IA
Published on 03/23/2026 at 11:06, 50 minutes ago Aroundtown SA: Release of a capital market information
Published on 03/23/2026 at 11:05, 52 minutes ago ASUS Unveils Complete Portfolio Support for Intel® Core™ 200S Series
Published on 03/23/2026 at 11:05, 52 minutes ago BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Published on 03/23/2026 at 08:10, 3 hours 47 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 16 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 16 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 17 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
